Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:933-942
doi: 10.1161/CIRCRESAHA.109.194464
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rochais, F.
Right arrow Articles by Kelly, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rochais, F.
Right arrow Articles by Kelly, R. G.
Related Collections
Right arrow Developmental biology
Right arrow Genetically altered mice
Right arrow Cardiac development
(Circulation Research. 2009;104:933.)
© 2009 American Heart Association, Inc.


Review

Signaling Pathways Controlling Second Heart Field Development

Francesca Rochais, Karim Mesbah, Robert G. Kelly

From the Developmental Biology Institute of Marseilles-Luminy, UMR 6216 Centre National de la Recherche Scientifique–Université de la Méditerranée, Campus de Luminy, Marseille, France.

Correspondence to Robert G. Kelly, IBDML, UMR 6216 CNRS-Université de la Méditerranée, Campus de Luminy, Case 907, 13288 Marseille Cedex 9, France. E-mail kelly{at}ibdml.univ-mrs.fr

Insight into the mechanisms underlying congenital heart defects and the use of stem cells for cardiac repair are major research goals in cardiovascular biology. In the early embryo, progenitor cells in pharyngeal mesoderm contribute to the rapid growth of the heart tube during looping morphogenesis. These progenitor cells constitute the second heart field (SHF) and were first identified in 2001. Direct or indirect perturbation of SHF addition to the heart results in congenital heart defects, including arterial pole alignment defects. Over the last 3 years, a number of studies have identified key intercellular signaling pathways that control the proliferation and deployment of SHF progenitor cells. Here, we review data concerning Wnt, fibroblast growth factor, bone morphogenetic protein, Hedgehog, and retinoic acid signaling that have begun to identify the ligand sources and responding cell types controlling SHF development. These studies have revealed the importance of signals from pharyngeal mesoderm itself, as well as critical inputs from adjacent pharyngeal epithelia and neural crest cells. Proliferation is emerging as a central checkpoint in the regulation of SHF development. Together, these studies contribute to defining the niche of cardiac progenitor cells in the early embryo, and we discuss the implications of these findings for the regulation of resident stem cell populations in the fetal and postnatal heart. Characterization of signals that maintain, expand, and regulate the differentiation of cardiac progenitor cells is essential for understanding both the etiology of congenital heart defects and the biomedical application of stem cell populations for cardiac repair.


Key Words: heart development • intercellular signaling • progenitor cells




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. D. Combs and K. E. Yutzey
Heart Valve Development: Regulatory Networks in Development and Disease
Circ. Res., August 28, 2009; 105(5): 408 - 421.
[Abstract] [Full Text] [PDF]